UPDATE: SVB Leerink Assumes Pfizer (PFE) at Market Perform

May 23, 2022 3:27 AM EDT
Get Alerts PFE Hot Sheet
Price: $52.31 -0.23%

Rating Summary:
    16 Buy, 15 Hold, 0 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 4 | Down: 13 | New: 10
Join SI Premium – FREE
(Updated - May 23, 2022 3:41 AM EDT)

SVB Leerink analyst Andrew Berens assumes coverage on Pfizer (NYSE: PFE) with a Market Perform rating and a price target of $55.00.

The analyst comments "We are initiating coverage of PFE shares with a Market Perform rating and a $55 price target. We are bullish on management’s initiatives to boost innovation, but we struggle to predict the magnitude and durability of COVIDrelated profits beyond 2022. Management is aggressively reinvesting outsized COVID-related cash flows in internal and external R&D to add long-term growth drivers and offset mid-late decade patent cliffs. But Core business prospects excluding transactions are uninspiring, and it is extremely difficult to predict the company’s earnings power as COVIDrelated sales decline after 2022."

For an analyst ratings summary and ratings history on Pfizer click here. For more ratings news on Pfizer click here.

Shares of Pfizer closed at $52.47 yesterday.


You May Also Be Interested In





Related Categories

Analyst Comments, New Coverage

Related Entities

Earnings, Andrew Berens